Dashboard PDUFA PDUFA History Dilution Watch Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Track XRTX with free AI briefings, catalyst countdowns, and dilution alerts.
Start 7-day free trial → Log in

XRTX · XORTX Therapeutics Inc.

Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.

$994,045 Cash on Hand
2.3mo Cash Runway
Follow XRTX by email Get an email when XRTX pushes back a promised milestone, files for a stock offering or has an FDA decision. Free, no account needed.

We send one confirmation email first. Only emails about XRTX, unsubscribe in one click. Privacy

💰 Cash Runway & Dilution Risk

XRTX holds $994,045 in cash and short-term investments and burns about $1.3M/quarter from operations, an estimated runway of 2.3 months at that rate (BioRadar estimate, not company guidance).

Dilution pressure: 40 · Elevated

Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when XRTX files for a raise →

Get the full XRTX picture

The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for XRTX and every other ticker you follow. Card required, cancel anytime.

Start 7-day free trial →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.